INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants
EuroIntervention 2018;13:1655-1661 published online May 2017. DOI: 10.4244/EIJ-D-17-00006
Matthias Sigler1*, MD; Björn Söderberg2, MD; Boris Schmitt3, MD; Andreas Mellmann4, Dipl.-Ing. FH; Jérôme Bernhard4, Dipl.-Ing. ETH
1. Pediatric Cardiology and Intensive Care Medicine, Georg-August University, Göttingen, Germany; 2. The Queen Silvia Children’s Hospital, Gothenburg, Sweden; 3. Department of Pediatric Cardiology, Deutsches Herzzentrum, Berlin, Germany; 4. CARAG AG, Baar
Aims: The aim of this study was to evaluate local biological responses to the partially bioresorbable non-metal frame Carag bioresorbable septal occluder system in an experimental setting